DE1938108C3 - Ein Granulat enthaltend ölige oder flüssige, therapeutisch verwendbare Furanoside - Google Patents
Ein Granulat enthaltend ölige oder flüssige, therapeutisch verwendbare FuranosideInfo
- Publication number
- DE1938108C3 DE1938108C3 DE1938108A DE1938108A DE1938108C3 DE 1938108 C3 DE1938108 C3 DE 1938108C3 DE 1938108 A DE1938108 A DE 1938108A DE 1938108 A DE1938108 A DE 1938108A DE 1938108 C3 DE1938108 C3 DE 1938108C3
- Authority
- DE
- Germany
- Prior art keywords
- radical
- weight
- benzyl
- parts
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008187 granular material Substances 0.000 title claims description 17
- 239000007788 liquid Substances 0.000 title claims description 10
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 claims description 11
- 239000000391 magnesium silicate Substances 0.000 claims description 11
- 229940099273 magnesium trisilicate Drugs 0.000 claims description 11
- 229910000386 magnesium trisilicate Inorganic materials 0.000 claims description 11
- 235000019793 magnesium trisilicate Nutrition 0.000 claims description 11
- -1 hydrocarbon radical Chemical class 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- ULLNJSBQMBKOJH-VIVFLBMVSA-N (3R,4R,5R)-5-[(1R)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol Chemical compound C([C@H]([C@H]1OC([C@@H]([C@H]1OCC=1C=CC=CC=1)O)OCC)OCC=1C=CC=CC=1)OCC1=CC=CC=C1 ULLNJSBQMBKOJH-VIVFLBMVSA-N 0.000 claims 1
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 claims 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000006277 halobenzyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000005923 long-lasting effect Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000003463 adsorbent Substances 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000008119 colloidal silica Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 235000012222 talc Nutrition 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- ULLNJSBQMBKOJH-JPHCZMGXSA-N (2s,3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol Chemical compound C([C@H]([C@H]1O[C@@H]([C@@H]([C@H]1OCC=1C=CC=CC=1)O)OCC)OCC=1C=CC=CC=1)OCC1=CC=CC=C1 ULLNJSBQMBKOJH-JPHCZMGXSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229960003567 tribenoside Drugs 0.000 description 3
- 238000002211 ultraviolet spectrum Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZUBVTGZFKATGNV-UHFFFAOYSA-N [Si]([O-])([O-])([O-])[O-].[Si]([O-])([O-])([O-])[O-].[Si]([O-])([O-])([O-])[O-].[Si+4].[Si+4].[Si+4] Chemical compound [Si]([O-])([O-])([O-])[O-].[Si]([O-])([O-])([O-])[O-].[Si]([O-])([O-])([O-])[O-].[Si+4].[Si+4].[Si+4] ZUBVTGZFKATGNV-UHFFFAOYSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- OAIVIYSBZFEOIU-UHFFFAOYSA-N chloroform;propan-2-one Chemical compound CC(C)=O.ClC(Cl)Cl OAIVIYSBZFEOIU-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1170468 | 1968-08-05 | ||
| CH1170468 | 1968-08-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE1938108A1 DE1938108A1 (de) | 1970-02-26 |
| DE1938108B DE1938108B (de) | 1973-05-17 |
| DE1938108C3 true DE1938108C3 (de) | 1974-01-03 |
Family
ID=4376070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1938108A Expired DE1938108C3 (de) | 1968-08-05 | 1969-07-26 | Ein Granulat enthaltend ölige oder flüssige, therapeutisch verwendbare Furanoside |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US3594474A (cg-RX-API-DMAC10.html) |
| AT (1) | AT290731B (cg-RX-API-DMAC10.html) |
| BE (1) | BE737053A (cg-RX-API-DMAC10.html) |
| BG (1) | BG17466A3 (cg-RX-API-DMAC10.html) |
| BR (1) | BR6911321D0 (cg-RX-API-DMAC10.html) |
| CA (1) | CA938889A (cg-RX-API-DMAC10.html) |
| CY (1) | CY790A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1938108C3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK123912B (cg-RX-API-DMAC10.html) |
| FI (1) | FI50058C (cg-RX-API-DMAC10.html) |
| FR (1) | FR2015053A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1259387A (cg-RX-API-DMAC10.html) |
| IE (1) | IE33246B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL32673A (cg-RX-API-DMAC10.html) |
| IT (1) | IT1035508B (cg-RX-API-DMAC10.html) |
| MY (1) | MY7500079A (cg-RX-API-DMAC10.html) |
| NL (1) | NL162837C (cg-RX-API-DMAC10.html) |
| NO (1) | NO129183B (cg-RX-API-DMAC10.html) |
| OA (1) | OA03604A (cg-RX-API-DMAC10.html) |
| PL (1) | PL88871B1 (cg-RX-API-DMAC10.html) |
| RO (1) | RO57881A (cg-RX-API-DMAC10.html) |
| SE (1) | SE363735B (cg-RX-API-DMAC10.html) |
| SU (1) | SU409407A3 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195078A (en) * | 1979-03-09 | 1980-03-25 | Eli Lilly And Company | Nabilone granulation |
| DE3773926D1 (de) * | 1987-07-22 | 1991-11-21 | Farvalsa Ag | Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung. |
-
1969
- 1969-07-22 IL IL32673A patent/IL32673A/en unknown
- 1969-07-23 CA CA057745A patent/CA938889A/en not_active Expired
- 1969-07-25 US US845038A patent/US3594474A/en not_active Expired - Lifetime
- 1969-07-26 DE DE1938108A patent/DE1938108C3/de not_active Expired
- 1969-07-29 FR FR6925823A patent/FR2015053A1/fr not_active Withdrawn
- 1969-07-29 IE IE1051/69A patent/IE33246B1/xx unknown
- 1969-07-30 FI FI692257A patent/FI50058C/fi active
- 1969-07-30 BG BG012772A patent/BG17466A3/xx unknown
- 1969-07-31 GB GB1259387D patent/GB1259387A/en not_active Expired
- 1969-07-31 CY CY790A patent/CY790A/xx unknown
- 1969-08-04 NO NO03188/69A patent/NO129183B/no unknown
- 1969-08-04 SU SU1356872A patent/SU409407A3/ru active
- 1969-08-04 NL NL6911864.A patent/NL162837C/xx not_active IP Right Cessation
- 1969-08-04 AT AT748569A patent/AT290731B/de not_active IP Right Cessation
- 1969-08-04 SE SE10870/69A patent/SE363735B/xx unknown
- 1969-08-04 DK DK418069AA patent/DK123912B/da not_active IP Right Cessation
- 1969-08-04 IT IT39194/69A patent/IT1035508B/it active
- 1969-08-04 BE BE737053D patent/BE737053A/xx not_active IP Right Cessation
- 1969-08-04 PL PL1969135222A patent/PL88871B1/pl unknown
- 1969-08-05 RO RO@@A patent/RO57881A/ro unknown
- 1969-08-05 OA OA53697A patent/OA03604A/xx unknown
- 1969-08-05 BR BR211321/69A patent/BR6911321D0/pt unknown
-
1970
- 1970-09-18 US US73606A patent/US3655870A/en not_active Expired - Lifetime
-
1975
- 1975-12-30 MY MY79/75A patent/MY7500079A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO129183B (cg-RX-API-DMAC10.html) | 1974-03-11 |
| AT290731B (de) | 1971-06-11 |
| CY790A (en) | 1976-06-01 |
| FI50058C (fi) | 1975-12-10 |
| IT1035508B (it) | 1979-10-20 |
| US3655870A (en) | 1972-04-11 |
| SU409407A3 (cg-RX-API-DMAC10.html) | 1973-11-30 |
| SE363735B (cg-RX-API-DMAC10.html) | 1974-02-04 |
| DE1938108A1 (de) | 1970-02-26 |
| FI50058B (cg-RX-API-DMAC10.html) | 1975-09-01 |
| DK123912B (da) | 1972-08-21 |
| CA938889A (en) | 1973-12-25 |
| BE737053A (cg-RX-API-DMAC10.html) | 1970-02-04 |
| RO57881A (cg-RX-API-DMAC10.html) | 1974-11-15 |
| NL6911864A (cg-RX-API-DMAC10.html) | 1970-02-09 |
| GB1259387A (cg-RX-API-DMAC10.html) | 1972-01-05 |
| IE33246L (en) | 1970-02-05 |
| US3594474A (en) | 1971-07-20 |
| MY7500079A (en) | 1975-12-31 |
| FR2015053A1 (cg-RX-API-DMAC10.html) | 1970-04-24 |
| IE33246B1 (en) | 1974-05-01 |
| IL32673A0 (en) | 1969-09-25 |
| BR6911321D0 (pt) | 1973-02-13 |
| BG17466A3 (bg) | 1973-11-10 |
| NL162837C (nl) | 1980-07-15 |
| NL162837B (nl) | 1980-02-15 |
| OA03604A (fr) | 1971-03-30 |
| IL32673A (en) | 1973-11-28 |
| PL88871B1 (cg-RX-API-DMAC10.html) | 1976-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1106454B (de) | UEberzugsmittel fuer Arzneistoffe | |
| DE2304065C3 (de) | Paste auf der Basis von in organischen Lösungsmitteln löslichen Hydroxy alkylacrylaten, oder Hydroxyalkylmethacrylaten | |
| DE1467976A1 (de) | Traegermassen fuer Pharmazeutika und Verfahren zu ihrer Herstellung | |
| CH659467A5 (de) | Verfahren zur herstellung von nifedipin-trockenpraeparaten. | |
| DE2822882A1 (de) | Nifedipine-enthaltende feste praeparatzusammensetzung, verfahren zu ihrer herstellung und ihre verwendung | |
| DE3228999A1 (de) | Pharmazeutische zusammensetzungen mit verzoegerter wirkstofffreigabe | |
| DE2454969C2 (de) | Verfahren zur Herstellung eines mit flüchtigen Stoffen beaufschlagten mineralischen Materials | |
| DE69014691T2 (de) | Verfahren zur Herstellung von Bromocriptin enthaltenden Arzneimittelzubereitungen mit hoher Stabilität und in Beziehung zueinander stehende Produkte. | |
| DE2246037B2 (de) | Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform | |
| CH641358A5 (de) | Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben. | |
| DE2706660A1 (de) | Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung | |
| DE69108007T2 (de) | Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung. | |
| DE2741755A1 (de) | Ueberzugsmassen auf polymerbasis fuer biologisch aktive praeparate und verfahren zur herstellung der ersteren sowie biologisch aktive praeparate und verfahren zur herstellung der letzteren | |
| DE69907495T2 (de) | (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on als reine verbindung | |
| DE69800357T2 (de) | Feste, nicht zerfliessbare formulierung von natrium valproat | |
| DE2240777A1 (de) | Verfahren zur herstellung eines kornfoermigen farbentwicklungsmittels | |
| DE1938108B (de) | Ein Granulat enthaltend ohge oder flussige, therapeutisch ver wendbare Furanoside | |
| EP0116358B1 (de) | Komplexe von Prostaglandinen | |
| DE3417576A1 (de) | Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung | |
| DE1492045A1 (de) | Verfahren zur Herstellung von oral zu verabreichenden therapeutisch aktiven Praeparationen mit langer Wirkungsdauer | |
| DE1492152B1 (de) | Anthelmintische,veterinaermedizinische Zubereitung | |
| DE102004005009A1 (de) | Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid | |
| DE1931910B2 (de) | Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe | |
| DE2127172A1 (de) | Arzneimittel zur Behandlung virus bedingter Infektionen | |
| DE2749745A1 (de) | Nitrofurantoin-retard-praeparat zur oralen verabfolgung und verfahren zu seiner herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| 8328 | Change in the person/name/address of the agent |
Free format text: REDIES, B., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 4000 DUESSELDORF |
|
| 8339 | Ceased/non-payment of the annual fee |